Annual Working Capital
$2.01 B
+$90.58 M+4.71%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual working capital is currently $2.01 billion, with the most recent change of +$90.58 million (+4.71%) on 31 December 2023. During the last 3 years, it has fallen by -$97.95 million (-4.64%). ALNY annual working capital is now -4.64% below its all-time high of $2.11 billion, reached on 31 December 2021.ALNY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.13 B
+$17.16 M+0.81%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly working capital is currently $2.13 billion, with the most recent change of +$17.16 million (+0.81%) on 30 September 2024. Over the past year, it has increased by +$119.85 million (+5.95%). ALNY quarterly working capital is now -1.65% below its all-time high of $2.17 billion, reached on 30 June 2021.ALNY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +6.0% |
| 3 y3 years | -4.6% | +1.0% |
| 5 y5 years | +47.8% | +56.6% |
ALNY Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.6% | +4.7% | at high | +23.0% |
| 5 y | 5 years | -4.6% | +47.8% | -1.6% | +71.3% |
| alltime | all time | -4.6% | >+9999.0% | -1.6% | >+9999.0% |
Alnylam Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.13 B(+0.8%) |
| June 2024 | - | $2.12 B(+3.5%) |
| Mar 2024 | - | $2.05 B(+1.6%) |
| Dec 2023 | $2.01 B(+4.7%) | $2.01 B(-1.0%) |
| Sept 2023 | - | $2.04 B(+17.3%) |
| June 2023 | - | $1.74 B(-7.1%) |
| Mar 2023 | - | $1.87 B(-2.9%) |
| Dec 2022 | $1.92 B(-8.9%) | $1.92 B(+0.3%) |
| Sept 2022 | - | $1.92 B(+5.7%) |
| June 2022 | - | $1.81 B(-8.6%) |
| Mar 2022 | - | $1.98 B(-6.1%) |
| Dec 2021 | $2.11 B(+4.1%) | $2.11 B(+2.3%) |
| Sept 2021 | - | $2.06 B(-4.9%) |
| June 2021 | - | $2.17 B(+47.1%) |
| Mar 2021 | - | $1.48 B(-27.3%) |
| Dec 2020 | $2.03 B(+48.9%) | $2.03 B(+28.9%) |
| Sept 2020 | - | $1.57 B(-11.4%) |
| June 2020 | - | $1.78 B(+42.5%) |
| Mar 2020 | - | $1.25 B(-8.6%) |
| Dec 2019 | $1.36 B(+33.5%) | $1.36 B(-11.7%) |
| Sept 2019 | - | $1.54 B(-11.0%) |
| June 2019 | - | $1.74 B(+39.6%) |
| Mar 2019 | - | $1.24 B(+21.7%) |
| Dec 2018 | $1.02 B(-37.0%) | $1.02 B(-16.3%) |
| Sept 2018 | - | $1.22 B(-12.1%) |
| June 2018 | - | $1.39 B(-11.5%) |
| Mar 2018 | - | $1.57 B(-3.1%) |
| Dec 2017 | $1.62 B(+200.0%) | $1.62 B(+81.6%) |
| Sept 2017 | - | $892.32 M(+4.7%) |
| June 2017 | - | $851.98 M(+69.9%) |
| Mar 2017 | - | $501.40 M(-7.2%) |
| Dec 2016 | $540.18 M(-48.2%) | $540.18 M(-18.9%) |
| Sept 2016 | - | $665.80 M(-18.6%) |
| June 2016 | - | $817.49 M(-16.9%) |
| Mar 2016 | - | $983.71 M(-5.7%) |
| Dec 2015 | $1.04 B(+60.3%) | $1.04 B(+6.0%) |
| Sept 2015 | - | $984.68 M(+2.3%) |
| June 2015 | - | $962.55 M(-4.6%) |
| Mar 2015 | - | $1.01 B(+55.1%) |
| Dec 2014 | $651.03 M | $651.03 M(+11.1%) |
| Sept 2014 | - | $586.17 M(-4.1%) |
| June 2014 | - | $611.38 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $590.23 M(+194.9%) |
| Dec 2013 | $200.16 M(+159.2%) | $200.16 M(+38.7%) |
| Sept 2013 | - | $144.27 M(-10.6%) |
| June 2013 | - | $161.29 M(-15.3%) |
| Mar 2013 | - | $190.36 M(+146.5%) |
| Dec 2012 | $77.21 M(+8.7%) | $77.21 M(-57.4%) |
| Sept 2012 | - | $181.18 M(-1.1%) |
| June 2012 | - | $183.28 M(+29.2%) |
| Mar 2012 | - | $141.90 M(+99.8%) |
| Dec 2011 | $71.04 M(-53.3%) | $71.04 M(-17.4%) |
| Sept 2011 | - | $86.03 M(-30.5%) |
| June 2011 | - | $123.80 M(-18.2%) |
| Mar 2011 | - | $151.37 M(-0.5%) |
| Dec 2010 | $152.09 M(-16.8%) | $152.09 M(+4.8%) |
| Sept 2010 | - | $145.19 M(-15.3%) |
| June 2010 | - | $171.48 M(-1.9%) |
| Mar 2010 | - | $174.74 M(-4.4%) |
| Dec 2009 | $182.80 M(-46.8%) | $182.80 M(+43.9%) |
| Sept 2009 | - | $127.04 M(-27.9%) |
| June 2009 | - | $176.09 M(-44.1%) |
| Mar 2009 | - | $315.09 M(-8.3%) |
| Dec 2008 | $343.67 M(+9.3%) | $343.67 M(-1.7%) |
| Sept 2008 | - | $349.75 M(-21.4%) |
| June 2008 | - | $444.90 M(+20.1%) |
| Mar 2008 | - | $370.56 M(+17.9%) |
| Dec 2007 | $314.43 M(+57.3%) | $314.43 M(-19.4%) |
| Sept 2007 | - | $390.18 M(+123.1%) |
| June 2007 | - | $174.85 M(-6.2%) |
| Mar 2007 | - | $186.42 M(-6.7%) |
| Dec 2006 | $199.86 M(+212.6%) | $199.86 M(+89.8%) |
| Sept 2006 | - | $105.30 M(-2.9%) |
| June 2006 | - | $108.46 M(-7.4%) |
| Mar 2006 | - | $117.13 M(+83.2%) |
| Dec 2005 | $63.93 M(+53.7%) | $63.93 M(+242.0%) |
| Sept 2005 | - | $18.70 M(-24.7%) |
| June 2005 | - | $24.82 M(-29.7%) |
| Mar 2005 | - | $35.30 M(-15.1%) |
| Dec 2004 | $41.61 M(+104.5%) | $41.61 M(+2.6%) |
| Sept 2004 | - | $40.56 M(-3.0%) |
| June 2004 | - | $41.81 M(+190.5%) |
| Mar 2004 | - | $14.39 M(-29.3%) |
| Dec 2003 | $20.34 M(+58.4%) | $20.34 M |
| Dec 2002 | $12.85 M | - |
FAQ
- What is Alnylam Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?
What is Alnylam Pharmaceuticals annual working capital?
The current annual working capital of ALNY is $2.01 B
What is the all time high annual working capital for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual working capital is $2.11 B
What is Alnylam Pharmaceuticals quarterly working capital?
The current quarterly working capital of ALNY is $2.13 B
What is the all time high quarterly working capital for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly working capital is $2.17 B
What is Alnylam Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ALNY quarterly working capital has changed by +$119.85 M (+5.95%)